返回 
加入收藏
右美托咪定对心肌肥厚模型家兔心律失常及心肌组织CaMKⅡ表达的影响
x
请在关注微信后，向客服人员索取文件
| 篇名： | 右美托咪定对心肌肥厚模型家兔心律失常及心肌组织CaMKⅡ表达的影响 |
| TITLE： | Effects of Dexmedetomidine on Ventricular Arrhythmia in Myocardial Hypertrophy Model Rabbits and CaMK Ⅱ Expression in Cardiac Tissue |
| 摘要： | 目的：研究右美托咪定对心肌肥厚模型家兔心律失常及心肌组织中钙离子-钙调蛋白依赖性蛋白激酶Ⅱ（CaMKⅡ）表达的影响。方法：将家兔随机分为假手术组，模型组，右美托咪定低、中、高剂量组（10、25、50μg/kg），CaMKⅡ抑制剂KN-93组（10mg/kg）和右美托咪定高剂量+KN-93组（50μg/kg+10mg/kg），每组10只。除假手术组外，其余各组家兔均采用腹主动脉缩窄术复制心肌肥厚模型。术后，各给药组家兔静脉注射相应剂量的右美托咪定或/和腹腔注射KN-93，假手术组和模型组家兔静脉注射等体积生理盐水，隔天给药1次，连续给药8周。末次给药后，采用程序性刺激诱发室性心律失常，记录各组家兔早期后除极（EAD）和尖端扭转型室性心动过速（Tdp）的诱发率，检测左室射血分数（LVEF）和左心室缩短分数（FS），记录离体楔形心肌组织QT间期、跨室壁复极离散度（TDR）和内、外膜心肌细胞跨膜动作电位复极90％时程（APD90），测量并计算心脏质量/体质量比值（HW/BW）以及左心室壁厚度（LVT），检测心肌细胞横截面积以及心肌组织中心房钠尿肽（ANP）和脑钠肽（BNP）mRNA以及CaMKⅡ、磷酸化CaMKⅡ（p-CaMKⅡ）蛋白的相对表达量。结果：与假手术组比较，模型组家兔EAD、Tdp诱发率和HW/BW、LVT以及心肌组织中ANP、BNPmRNA的相对表达量和CaMKⅡ、p-CaMKⅡ蛋白的相对表达量均显著升高，LVEF、FS均显著降低，QT间期和内、外膜心肌APD90均显著延长，TDR显著增加，心肌细胞横截面积显著增大（P＜0.05）。与模型组比较，各给药组家兔EAD、Tdp诱发率和HW/BW（右美托咪定低剂量组除外）、LVT（右美托咪定低剂量组除外）以及心肌组织中ANPmRNA（右美托咪定低剂量组除外）、BNPmRNA（右美托咪定低剂量组除外）的相对表达量和CaMKⅡ、p-CaMKⅡ蛋白的相对表达量均显著降低，LVEF（右美托咪定低剂量组除外）、FS（右美托咪定低剂量组除外）均显著升高，QT间期和内、外膜心肌APD90均显著缩短，TDR均显著减小，心肌细胞横截面积（右美托咪定低剂量组除外）均显著缩小（P＜0.05），且右美托咪定高剂量组的改善效果优于右美托咪定低、中剂量组（P＜0.05）。与右美托咪定高剂量组和KN-93组比较，右美托咪定高剂量+KN-93组家兔上述指标的改善更明显（P＜0.05）。结论：右美托咪定可降低心肌肥厚模型家兔心律失常的诱发率，改善其心肌肥厚，其机制可能与下调CaMKⅡ表达有关。 |
| ABSTRACT： | OBJECTIVE：To study th e effects of dexmedetomidine on ventricular arrhythmia in myocardial hypertrophy model rabbits and the expression of calcium ion /calmodulin-dependent protein kinase Ⅱ（CaMKⅡ）in myocardial tissue of rabbits. METHODS： The rabbits were randomly divided into sham operation group ， model group ， dexmedetomidine low-dose ， medium-dose and high-dose groups （10，25，50 μ g/kg），CaMK Ⅱ inhibitor KN- 93 group （10 mg/kg），high-dose of dexmedetomidine+KN-93 group（50 μg/kg+10 mg/kg），with 10 rabbits in each group. Except for the sham operation group ，other groups received abdominal aortic coarctation to induce myocardial hypertrophy model. After surgery ，administration groups were given relevant dose of dexmedetomidine or/and intraperitoneal injection of KN- 93；sham operation group and model group were given constant volume of normal saline intravenously ，once every other day ，for consecutive 8 weeks. After last medication ， programmed stimulation was used to induce ventricular arrhythmia. The induction rate of early posterior depolarization （EAD）and tip torsion type ventricular tachycardia （Tdp）were recorded. Left ventricular ejection fraction （LVEF）and left ventricular shortener fraction（FS）were measured. QT interval ，transventricular wall repolarization dispersion （TDR）and transmembrane 90％ action potential duration （APD90）of endocardial and epicardial cardiomyocytes in wedge-shaped myocardium were recorded. The ratio of heart weight to body weight （HW/BW）and the thickness of left ventricular wall （LVT）were measured and calculated. The cross-sectional area of cardiomyocytes ，mRNA expression of ANP and BNP as well as protein expression of CaMK Ⅱ and p-CaMK Ⅱ in myocardial tissue was measured. RESULTS ：Compared with sham operation group ，the induction rate of EAD and Tdp ，HW/BM， LVT，mRNA expression of ANP and BNP and protein relative expression of CaMK Ⅱ and p-CaMK Ⅱ in cardiac tissue were all increased significantly ，while LVEF and FS were decreased significantly ；QT interval ，APD90 of endocardial and epicardial cardiomyocytes were all prolonged significantly ；TDR was increased significantly ，while cross-sectional area of cardiomyocytes was increased significantly in model group （P＜0.05）. Compared with model group ，induction rate of EAD and Tdp ，HW/BW （except for dexmedetomidine low-dose group ），LVT（except for dexmedetomidine low-dose group ），mRNA relative expression of ANP（except for dexmedetomidine low-dose group ）and BNP （except for dexmedetomidine low-dose group ）as well as protein relative expression of CaMK Ⅱ and p-CaMK Ⅱ were all decreased significantly in administration groups ；the levels of LVEF （except for dexmedetomidine low-dose group ） and FS （except for dexmedetomidine low-dose group ） were all increased significantly； QT interval ，APD90 of endocardial and epicardial cardiomyocytes were shortened significantly ； TDR and cross-sectional area of cardiomyocytes （except for dexmedetomidine low-dose group ）were decreased significantly （P＜0.05）；the improvement effects of dexmedetomidine high-dose group were significantly better than those of dexmedetomidine low-dose and medium-dose groups （P＜0.05）. Compared with dexmedetomidine high-dose group and KN- 93 group，the improvement of above indexes were all more significant in high-dose of dexmedetomidine+KN- 93 group（P＜0.05）. CONCLUSIONS ：Dexmedetomidine can reduce the induction rate of ventricular arrhythmia and improve myocardial hypertrophy in myocardial hypertrophy model rabbits，the mechanism of which may be associated with down-regulation of CaMK Ⅱ expression. |
| 期刊： | 2021年第32卷第18期 |
| 作者： | 刘旭东，赵亮，曹雪峰，胡杰 |
| AUTHORS： | LIU Xudong ，ZHAO Liang，CAO Xuefeng ，HU Jie |
| 关键字： | 右美托咪定；心肌肥厚；心律失常；钙离子-钙调蛋白依赖性蛋白激酶Ⅱ；家兔 |
| KEYWORDS： | Dexmedetomidine；Myocardial hypertrop hy；Ventricular arrhythmia ；CaMKⅡ；Rabbit |
| 阅读数： | 338 次 |
| 本月下载数： | 5 次 |
* 注：未经本站明确许可，任何网站不得非法盗链资源下载连接及抄袭本站原创内容资源!在此感谢您的支持与合作！
